by Virtus | Apr 11, 2026 | Viral & Rhinovirus Models
Viral challenge preclinical studies are used in respiratory preclinical research to evaluate how therapeutic candidates perform under controlled viral infection conditions. These studies are commonly applied in respiratory drug development to investigate antiviral...
by Virtus | Apr 11, 2026 | Early-Stage Respiratory Drug Development
Finding the best respiratory CRO in the UK is a key step for biotech and pharmaceutical companies developing therapies for asthma, COPD, and viral respiratory diseases. Respiratory drug development requires specialised preclinical models, in vivo respiratory studies,...
by Virtus | Mar 21, 2026 | Respiratory Preclinical Research
Asthma vs COPD preclinical models are frequently compared in respiratory preclinical research because both disease areas require distinct experimental systems to evaluate therapeutic efficacy. While asthma preclinical models focus on immune-mediated airway...
by Virtus | Mar 21, 2026 | Early-Stage Respiratory Drug Development
Selecting a respiratory preclinical CRO in the UK is a key decision in early stage respiratory drug development. Respiratory diseases such as asthma, COPD, and viral respiratory infections require disease-specific preclinical models, in vivo respiratory studies, and...
by Virtus | Mar 21, 2026 | Early-Stage Respiratory Drug Development
Preclinical feasibility studies respiratory programmes are used in early stage respiratory drug development to evaluate whether a therapeutic candidate demonstrates sufficient biological activity to justify further progression. These studies are typically designed to...
